~~<i id='617895D854'><strike id='617895D854'><tt id='617895D854'><pre id='617895D854'></pre></tt></strike></i>~~

Home» comprehensive» comprehensive

comprehensive

author：leisure time 2025-08-21 16:35:27 Page View：9491

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： North Korean leader's powerful sister says warplanes repelled US spy plane
Next article： Medical records are filled with copy

explore

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

Titanic submersible: What a 'catastrophic implosion' means and what officials found

5:55TheTitansubmersible,operatedbyOceanGateExpeditionstoexplorethewreckageofthesunkenSSTitanicoffthe

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

JPM: CVS says Medicare Advantage patients are impacting profits

WilfredoLee/APMedicareAdvantagememberscontinuetogotothedoctorandgethealthcareproceduresalotmorethanp